Overview
Chloroquine is a 4-aminoquinoline compound long used as an antimalarial and antirheumatic agent, acting principally as a weak base that accumulates within acidic intracellular compartments and raises endosomal and lysosomal pH. In the malaria parasite this interferes with heme detoxification in the digestive vacuole; in other contexts the same alkalinizing effect impairs endosomal acidification, antigen processing, and autophagy. These properties prompted investigation of chloroquine and its hydroxylated analogue, hydroxychloroquine, as candidate antivirals during the COVID-19 pandemic, on the hypothesis that raised endosomal pH might hinder viral entry and post-entry processing of SARS-CoV-2. Clinical evaluation examined viral kinetics in mild disease treated with chloroquine-containing regimens versus standard of care, and assessed effects on clinical improvement and mortality in hospitalized patients. The drug class carries a defined toxicity profile, notably QT-interval prolongation, retinal injury with prolonged exposure, and gastrointestinal effects, which constrain dosing and demand monitoring. Pharmacologically, chloroquine illustrates how a single mechanism, lysosomotropic accumulation, can underlie activity against unrelated targets spanning protozoal infection, autoimmune inflammation, and viral replication. Research in this area weighs in vitro plausibility against controlled clinical evidence, the central question being whether laboratory activity translates into measurable patient benefit.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Malaria: An Unseen Enemy Threatening to Mankind
Effect of Hydroxychloroquine on Clinical Improvement and Mortality Among Patients with COVID-19 Admitted to Four General Hospitals in Saudi Arabia
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
How this research is being cited
The 5 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2025 · Inflammopharmacology
-
2025 · Inflammopharmacology
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
2020 · Jurnal Ilmu Administrasi Media Pengembangan Ilmu dan Praktek Administrasi
-
2020 · Jurnal Ilmu Administrasi: Media Pengembangan Ilmu dan Praktek Administrasi
-
2019 · Journal of Experimental and Clinical Toxicology
A sample of recent works citing this journal's research on Chloroquine, linking to each citing work.